Crossmark Global Holdings Inc. Purchases 11,726 Shares of Dolby Laboratories $DLB

Crossmark Global Holdings Inc. lifted its position in shares of Dolby Laboratories (NYSE:DLBFree Report) by 36.1% in the fourth quarter, HoldingsChannel reports. The fund owned 44,208 shares of the electronics maker’s stock after buying an additional 11,726 shares during the period. Crossmark Global Holdings Inc.’s holdings in Dolby Laboratories were worth $2,839,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Horizon Corp bought a new stake in shares of Dolby Laboratories during the third quarter worth $25,000. Hantz Financial Services Inc. raised its position in shares of Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after acquiring an additional 220 shares during the last quarter. Rothschild Investment LLC raised its position in shares of Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after acquiring an additional 607 shares during the last quarter. Fifth Third Bancorp raised its position in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after acquiring an additional 192 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of Dolby Laboratories during the third quarter worth $50,000. Institutional investors own 58.56% of the company’s stock.

Insiders Place Their Bets

In other Dolby Laboratories news, SVP John D. Couling sold 7,666 shares of the stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $57.55, for a total value of $441,178.30. Following the completion of the sale, the senior vice president directly owned 118,353 shares in the company, valued at $6,811,215.15. This represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ryan Nicholson sold 2,667 shares of the stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $66.38, for a total value of $177,035.46. Following the completion of the sale, the chief accounting officer owned 36,956 shares of the company’s stock, valued at $2,453,139.28. This trade represents a 6.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 18,021 shares of company stock worth $1,090,741 over the last ninety days. 37.93% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on DLB shares. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, January 30th. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average target price of $90.75.

View Our Latest Report on Dolby Laboratories

Dolby Laboratories Trading Down 0.9%

NYSE DLB opened at $57.64 on Tuesday. The stock has a 50-day simple moving average of $61.96 and a 200 day simple moving average of $64.11. The company has a market capitalization of $5.45 billion, a PE ratio of 22.78 and a beta of 0.86. Dolby Laboratories has a 12 month low of $55.73 and a 12 month high of $78.28.

Dolby Laboratories (NYSE:DLBGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the prior year, the company posted $1.34 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, sell-side analysts predict that Dolby Laboratories will post 3.22 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be issued a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio is 56.92%.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.